Wi-Fi, smart meters, cell phones, cell phone towers, and cordless phones are just a few of the many items in our environment with electromagnetic fields (EMFs)—invisible forces that interact with our body every day. To date, at least eight different effects of EMFs have been identified, each demonstrated and reviewed by 12-35 articles. These effects impact neurological and neuropsychiatric function in a cumulative fashion—the higher the number of exposures, the more severe the effects; eventually they become irreversible, and can cause anything from the inability to sleep, anxiety, the inability to concentration, depression, poor memory, and headaches. So, what is the mechanism by which this occurs and what’s being done about it?
Dr. Martin Pall, Ph.D. is a professor at Washington State University who joins the podcast to answer these questions and more. He focuses his work on understanding the relationship between EMFs and the activation of voltage-gated calcium channels, which are present in every cell membrane in the body, but play a particularly important role in electrically active tissues, such as the nervous system and heart, as well as the release of hormones and neurotransmitters. He explains that the electrical forces produced by EMFs impose a force on the voltage sensor that’s 7.2 million times stronger than the force imposed by the cells in our body. Throughout the discussion, Dr. Pall touches on a range of topics, including his concerns about imminent 5G technology, the difference between the intensity of radiation and the intensity of effect, exposure windows, and different types of DNA damage shown to be caused by EMFs.
Tune in for all the details, including tips for finding the best resources to learn more.
As a participant of the Personal Genome Project (PGP), which was initiated in 2005 at Harvard Medical School, James Turner has donated a significant amount of information to the project, including an extensive personal health survey, 20 years’ worth of notes pertaining to doctor visits, lab tests, treatments, etc., and MRI images. Once submitted to the PGP, a participant’s information becomes available to any all researchers for the purposes of driving genetic research. The program has two main goals: to perform whole genome sequencing on as many samples as possible, and to correlate the genetic information obtained with phenotypic data.
As a descendent of the PGP, the Open Humans Foundation takes a slightly different approach to the same idea; it allows participants to choose whether they want their data to be available to everyone or only select researchers, works to facilitate the transfer of information from personal devices to biological data banks, and makes use of data inspired by the Quantified Self Movement (e.g. Fitbit/Apple Watch, diet data). Turner now serves as the treasurer and chairman of this foundation, and he joins the podcast to provide unique insight on the world of genomic data and biological research driven by the people.
Press play to hear the full conversation, and visit <a href="https://www.personalgenomes.org/us">https://www.personalgenomes.org/us</a> and <a href="http://openhumansfoundation.org/">http://openhumansfoundation.org/</a> to learn more.
Jake A. Kushner M.D., Medical Director, McNair Interests, provides a thorough overview of his research and study of diabetes.
Currently, Dr. Kushner serves as the Medical Director for McNair Interests. He is a renowned diabetes researcher as well as a pediatric endocrinologist with a particular expertise in biotechnology, biomedical research, type 1 diabetes and other specific endocrine disorders. Dr. Kushner is the former Chief of Pediatric Diabetes and Endocrinology and McNair Medical Institute Scholar at the Baylor College of Medicine and Texas Children’s Hospital. He has worked with the National Institutes of Health, served on the type 1 diabetes advisory council for Lexicon Corporation, and been a strategic advisor for Sanofi.
Dr. Kushner discusses his background as a pediatric endocrinologist and how he came to be interested in the research and study of diabetes. Dr. Kushner is a respected, nationally recognized expert in type 1 diabetes research. His background in medicine is significant and includes endocrinology and diabetes, specifically caring for children with type 1 diabetes, as well as cystic fibrosis-related diabetes, and treating children who have hypoglycemia. He explains type 1 diabetes, and talks about how it affects many people worldwide.
Dr. Kushner delves into the complex issue of insulin and how the body reacts and responds to nutrients. He explains in detail, the storage of glucose, carbohydrates, and how the body processes everything that comes into it, as well as how stress affects everything. He talks at length about the kinds of meals that people eat, and explains how specific foods are processed by the body for use, including what the body needs, especially for those who have special dietary requirements due to health conditions or disease.
Dr. Kushner is a UC Berkeley graduate and earned a medical degree from Albany Medical College in New York. Dr. Kushner completed his medical residency in pediatrics at Brown University. Additionally, Dr. Kushner engaged in a clinical fellowship at Children's Hospital Boston and a prestigious research fellowship at the Joslin Diabetes Center, the world’s largest diabetes research center, at Harvard Medical School in Boston.
In this informative podcast, Joan E. Nichols, Ph.D., professor, and a lead researcher, University of Texas Medical Branch at Galveston, provides an overview of the lung, and her lab’s important work developing bioengineered tissue.
The celebrated Ph.D. discusses how she settled into bioengineering for her life’s work, and her motivation to study organs. She explains the incredible need for lungs and other organs, and how so many people are waiting for transplants to save their lives. Her lab hopes to be a part of this process, as their work is primarily in the area of developing bioengineered tissues.
Nichols explains why she chooses to research certain areas of science and outlines her interest in the variations within the human immune response to specific microbial pathogens. Her lab studies reaction and response of the lung after certain exposures to various pollutants, as well as respiratory pathogens. In addition, their research includes the study of disease pathogenesis, as well as inflammation, stem cell-based treatments, and more.
By utilizing adult and embryonic stem cells as well as advanced tissue engineering techniques to create human ex-vivo organoids/tissue constructs, they seek to create intricate human model systems to study disease pathogenesis and the complex human responses to pathogens. The Ph.D. explains the structure of the lung, covering topics such as gas exchange and the mechanisms of the lung.
As an Earth observation application engineer at the European Space Agency, Benjamin Koetz spends his time trying to figure out how Earth functions by tracking patterns from space that can’t be seen from the ground, monitoring different environmental processes, collecting data regarding human activities, and making sure that information gathered from satellites is conflated into something that’s useful for the management of natural resources.
He joins the podcast today to discuss all the details of these activities and more, including the different types of observation techniques they employ, applications for Earth observation data, the advantages of having a global view from space, the environmental trends being observed from space, food security intervention efforts informed by the data they gather, laser observation, and the resolution of satellites.
Tune in for all the details, and search the web for real-time satellite images of Earth from space.
What does dentistry have to do with epigenetics? Dr. Ted Belfor was a practicing dentist for decades before he could answer that question. In fact, when he began talking about epigenetics twenty years, no one even knew what he was talking about. Today, epigenetics is arguably the largest science of the 21st century. Dr. Belfor joins the podcast to discuss what he’s learned over the years about the overlap between epigenetics, craniofacial development, and sleep disorders.
While the environment can’t change our genes, it can determine how our genes are expressed. Dr. Belfor explains that, due in large part to our diets now consisting of over 60 percent processed foods, we haven’t been chewing and swallowing the way we were designed to, and as a result, we aren’t fully expressing our genes for facial development. Expression of these genes can be stimulated by oral appliances and breathing exercises that work to tone the airway and enhance the growth of the jaw. When craniofacial development occurs properly and airways are toned, breathing problems such as apnea and upper airway resistance during sleep simply don’t exist.
In order to help people combat these problems, Dr. Belfor has created a removable oral appliance called the Homeoblock that imitates nature by putting the force back in our chew and imitating the signaling of the periodontal ligament, which he explains is crucial to proper development. He discusses a variety of other interesting topics, including the differences between sleep apnea and upper airway resistance and why one is actually significantly more detrimental than the other, how proper alignment of the jaw improves homeostatic capacity and the ability for the body to maintain a healthy state, the consequences of mouth breathing, and how to go about getting a Homeoblock for yourself. Tune in and visit <a href="http://www.facialdevelopment.com/aboutus.php">http://www.facialdevelopment.com/aboutus.php</a> to learn more.
Giuseppe Loianno, Assistant Professor in the Electrical and Computer Engineering Department as well as the Mechanical and Aerospace Engineering Department, Tandon School of Engineering, New York University, discusses his robotics lab’s work.
Loianno is a passionate professor with a deep interest in many types of applied engineering. Loianno runs the Agile Robotics and Perception Lab (ARPL), a lab that is heavily involved in fundamental and applied research as it pertains to robotics autonomy. Their work is primarily focused on the creation of agile autonomous machines that can navigate independently using nothing more than onboard sensors in unstructured, and dynamically altering environments, without GPS or motion capture, etc. The researchers seek to refine and develop further, active machines that can collaborate with humans and with each other, and perform at an optimum level in unknown environments.
Loianno discusses eye-tracking glasses and the control of drones with the eye. He explains the benefits of eye tracking, and how it can make drone use easier and smoother. He states that this technology is non-invasive and exceptionally easy to use. While this technology is early-stage, Loianno is hopeful that new computer vision algorithms will help further their development. As he explains, gesture and voice interaction can also be utilized to better control the drones and improve robotic development.
The applied engineering expert talks about some of their current trials and the new data they are gathering to further technological development. He envisions a complete framework that will incorporate multiple robots for control by a single user, then multiple users. Ultimately, these machines will be able to improve human work, in our environment and even in space, performing advance work that will inform humans about unknown environments, safety issues, and so much more.
Loianno discusses how line of sight control can be switched to camera control when drones are out of range. And he answers specific questions regarding the complexities of line of sight issues. Loianno discusses the necessary training that users will need to control the technology in various environments. As he states, one of the greatest attributes of this tech is the interaction with humans… in that, the robotic drones can perform analyses and relay the information in real time to the human partner, for various tasks.
Just a few decades ago, medicine was an entirely different animal than it is now—one in which exploratory surgeries were undergone more or less without hesitation in order to rule out differential diagnoses, palpation was one of the primary ways to diagnose appendicitis, and microbes were seen only as the enemy, as germs that were bad for us. Today, diagnostic imaging is arguably the fulcrum of medical diagnoses, and a growing body of research is indicating that the microbiome has an influential role in almost every function of our bodies, from growth and development to mate selection and behavior. But how are radiology and microbiota related?
That question is perhaps best answered by Dr. William B. Miller Jr., radiologist, evolutionary biologist, author of The Microcosm Within: Evolution and Extinction in the Hologenome, and lecturer on the emerging science of the hologenome. For him, the point at which he realized that diseases form reliably identifiable patterns on x-rays, magnetic resonance imaging (MRI), ultrasound, and computed tomography (CT) was the point at which he began to realize that individual organisms should be seen through a lens that encompasses all of the microbes that interact with it.
Dr. Miller is an endless source of interesting information, discussing a range of topics to include the influential role of the microbiome in our daily lives, how infectious diseases produce the same patterns as metastatic cancer on MRI, CT, ultrasound, and x-ray images, repeating patterns in nature, different forms of intelligence, and how to define and understand cellular self-awareness. Press play for the full conversation, visit <a href="http://www.themicrocosmwithin.com">www.themicrocosmwithin.com</a> to learn more, and find his book on Amazon or in the stores.
Mariano Vázquez, Ph.D., co-founder, and CTO of ELEM Biotech, discusses the many possibilities for testing and advancing treatments by utilizing virtual humans.
Mariano Vázquez, Ph.D., has spent many years as a prominent researcher at the Barcelona Supercomputing Center and he has worked in tandem with many multi-disciplinary, international researchers with diverse backgrounds spanning physics, mathematics, computer sciences, and engineering. By activating the most powerful supercomputers on the planet, researchers seek to gather a more sophisticated understanding of nature by developing a computational world for their ongoing research.
Vázquez talks about their work at ELEM Biotech. Their simulations of complex systems such as the human body, open up many doors for further research and testing. Overall the company is immersed in biomedical simulations, cloud, machine learning, the cardiovascular system, and the respiratory system, advanced medical devices, etc. Vázquez explains that while ELEM Biotech is interested in many areas of study and development, they are mostly focused on the cardiovascular system. Their information states… “Imagine a virtual human, not made of flesh and bones, but bits and bytes.”
As Vázquez explains, they create virtual humans with the goal of facilitating the testing of medical devices and pharmaceuticals, etc. Ultimately, virtual humans are created in a cloud infrastructure, where pharmaceutical companies, medical device manufacturers, etc. can test their products and fine-tune treatments to best-fit patients. In theory, so many devices and systems can be tested, from pacemakers to valve replacements, as well as stents and anti-arrhythmic drugs. Additionally, treatments for asthma, obstructive pulmonary diseases and so much more can be set up for study.
Vázquez talks about the future study they hope to approach. He explains the manner in which they develop their models and the relative complexity. He details how they combine systems to work in coordination. He further elaborates on their desire to link systems in a more advanced way, such as the cardiovascular and respiratory systems. Vázquez explains also, the wonderful possibilities to test devices in relation to male versus female, for as he states a pacemaker, for example, is designed for both male and female, but the hearts are different.
Finally, Vázquez talks about the research and development they expect to delve into in the coming months and years
According to a meta-analysis study in 2015 that considered 226 studies, the practice of oral and breathing exercises lowered subjects' apnea–hypopnea index (an index of the severity of apnea based on how many times and for how long breathing ceases per hour of sleep) by 50%. So, what exactly are oral exercises? It may sound a little odd at first, but Sarah Hornsby is a myofunctional therapist who teaches people how to strengthen their tongue, throat, breathe through their nose, and keep their tongue resting at the roof rather than the bottom of their mouth through a series of exercises she leads via Skype-based appointments, video programs, and YouTube videos. Her goal is to make this knowledge and resource globally accessible to the many people who are unnecessarily suffering or unaware that there is an actual fixable problem underlying their daily fatigue.
“It really is something that actually addresses root causes, and I appreciate that so much because I feel like a lot of what we do in modern medicine and dentistry is just about treating symptoms,” says Hornsby. In addition to sleep apnea, headaches, jaw pain, neck pain, teeth grinding, and chronic sinus issues are just a few of the symptoms associated with oral myofunctional and breathing problems. Ultimately, a person’s overall health and well-being can be severely compromised by something that's treatable without the use of pills or bothersome devices.
Hornsby makes for an insightful and eye-opening conversation that covers everything from craniofacial development and growth in children (and how it can be altered by the position of the tongue in the mouth), why snoring shouldn’t be brushed off as simply a nuisance, the importance of the respiratory disturbance index in evaluating the seriousness of a person’s sleep apnea, and what an initial consultation with her would look like.
Press play to hear the full conversation, find her videos on YouTube, and visit https://myfaceology.com/ to learn more.
About two years ago, a group of highly talented senior researchers from a startup named Unanimous approached Dr. Matthew Lungren, assistant professor of pediatric radiology at Stanford University Medical Center, with an inquiry: in what ways, if any, could technology designed to harness the power of collective human intelligence benefit the world of radiology or medicine in general? A collaboration between these researchers and Dr. Lungren commenced soon after, around the time when Stanford researchers released data showing that the detection of pneumonia on x-ray could be accomplished by AI with the same level of accuracy as human radiologists. The investigative question then became whether or not collective human intelligence could outperform the independent power of both AI and human radiologists.
So, what exactly is collective or ‘swarm’ intelligence and how is it better than just having a conversation with colleagues about a particular problem or decision? Dr. Lungren describes it like this: “If you can imagine a puck on ice that can be slid around, and each person has a magnetic force that they can apply to that puck to pull it toward the answer they believe is correct…eventually a decision is reached…and it’s fascinating to see how accurate they end up being as a group.” Unlike sitting around a table with your colleagues and eventually coming to a conclusion, no one knows the identity of anyone else in the swarm, which immediately eliminates the hierarchical and sociological influences of decision-making processes that involve perceived leaders or people of power; even if subtle, the dynamics that emerge from such heterogeneous groups often play influential roles on the final decisions that are made. Swarm intelligence removes that influence, and replaces it with distributed anonymity in decision making.
The possible use cases of this technology extend far beyond the world of radiology and hold promise for a future filled with better, more accurate diagnoses and decision making in medicine, but that’s not to say it’s not without its challenges and drawbacks. Press play to hear the full conversation, learn more by visiting the web page of the ones who started it all (unanimous.ai) and feel free to email your questions to Dr. Lungren at <a href="mailto:firstname.lastname@example.org">email@example.com</a>.
In Canada, 27 people are going to die today because of an adverse drug reaction, and in the US, ten times that number will die for the same reason. But with the right patient-specific prescribing software and enough time for thorough patient-doctor conversations prior to choosing or prescribing a new medication, many of these deaths can be prevented.
GenXys is a company that’s developed software that considers every relevant aspect of an individual's health history, current health status, and current drug list before providing a comprehensive list of the drugs that could be used to treat a particular condition, along with information about risk factors, warnings, adverse drug interactions, efficacy, and more. Current drug interaction software programs are designed to send alerts only after a drug has been chosen, thereby acting as more of an afterthought warning for what’s already been decided. GenXys software delivers these warnings to clinicians before they even sit down for the discussion with their patients.
“In the end, what we’re trying to do is give the physician and the patient all the drug options and the information about those drugs options precisely and very, very quickly…you want to have the time in the consultation focused on the discussion, not on the software, so our aim is to make the software almost in the background, so you don’t notice it as the clinician or as the patient,” says Dr. Martin Dawes, MD, Co-Founder, and Chief Scientific Officer of GenXys. He brings a wealth of information to the conversation, discussing the current state of affairs in drug development and approval, the current process of deciding upon and prescribing drugs, and the importance of changing the status quo in these areas. Press play for the full conversation, and visit <a href="https://www.genxys.com/content/">https://www.genxys.com/content/</a> to learn more.
Bacteria, yeast, and viruses inhabit our mouths, but the role they play in the overall health of our bodies is just beginning to be explored. Currently, factors contributing to sick mouths are being cross-referenced and studied with up to 57 systemic diseases—diseases that would otherwise seem unrelated to oral health, such as colorectal cancer, diabetes, cardiovascular disease, pancreatic cancer, chronic high blood pressure, sleep apnea, and even dementia.
Dr. Doug Thompson runs his own practice that’s based around the mouth-body connection and aptly named Integrative Oral Medicine. “You can’t separate the mouth from the body; it’s absolutely integrated, and as dentists become more and more aware, they’re helping patients become a lot healthier,” he says. He joins the podcast to discuss the specifics of how poor oral health contributes to and indicates the presence of other diseases, and how medical doctors and dentists can collaborate to identify these connections and improve—and sometimes even save—the lives of their patients.
Dr. Thompson is also the founder of the Wellness Dentistry Network, which he uses as a platform to teach dentists how to provide better care to their patients by embracing a more holistic view of oral health and to provide resources on best practices and new methodologies in the field.
Visit <a href="https://ioralmed.com/">https://ioralmed.com/</a> and <a href="https://www.wellnessdentistrynetwork.com/">https://www.wellnessdentistrynetwork.com/</a> to learn more.
Dr. Eric Scerri, noted scientist and author of the book, “The Periodic Table: Its Story and Its Significance,” and many others, delivers a fascinating overview of the origin and importance of the periodic table.
Dr. Scerri is an experienced scientist who has logged many years in the field of chemistry. His formal education was primarily with the Universities of London, Cambridge, and Southampton. Interested in sharing his love of science with hungry young minds, Dr. Scerri spent a decade teaching chemistry at various private colleges in the London area. Dr. Scerri completed postdoctoral fellowships with the London School of Economics and Caltech then went on to teach again at Purdue University and Bradley University, eventually landing at UCLA in 2000.
The science expert talks about his background and how he became interested in the periodic table in his early childhood years. He recounts how the periodic table truly encompasses all the stuff from which everything is made. No other science has anything quite like it, which is remarkable and makes the periodic table that much more intriguing scientifically. He talks in depth about some of the more obscure elements and where they exist or might exist, in the universe. And he provides detailed information about the life of elements and their half-lives.
The chemist talks about the origin of the periodic table, as well as the discovery of the atom, etc. He explains many surprising insights that he has encountered in relation to the early equations that explained the complexity of the atom. He goes into detail about various equations from the pioneers of quantum mechanics that set out to explain the periodic table.
Dr. Scerri goes on to explain how superficial behavior can be misleading, and that deeper examination is required to fully explain and classify elements within scientific study. He talks about how every object is quantum mechanical, and that quantum mechanics is the more fundamental theory. Dr. Scerri discusses the various areas of his study and recounts some of the commonly asked questions he has fielded over the years in the many and various interviews he has taken part in.
Additionally, the science author explains how there is a fundamental unity of everything, and how this concept is often lacking in western philosophy and literature. He talks in detail about how science is, in fact, one unifying area, and that the individuals are less important than the overall advancement of science.
It’s only within the last decade or so that there’s been an understanding and growing appreciation of the ways in which cancer cells interact with the body, and the important clinical impacts of these interactions. Prior to this, the main focus was on developing therapies that only targeted the tumors themselves. However, due to the hyper-evolving nature of cancer cells and their ability to manipulate and adapt to the environment in ways that promote their growth, therapies designed to attack only them don’t always provide clinical benefit for the patient.
Masoud Tavazoie, MD, Ph.D., is the CEO and co-founder of Rgenix, a company with a scientific approach to this problem that models the interactions between tumors and tumor microenvironments to not only learn more about the ways in which tumors communicate with the body, but also identify specific targets on immune cells that, when provided with novel therapeutics, will bolster the body’s ability to mount an effective response against tumor growth. Since the therapies being developed by Rgenix don’t necessarily act on the cancer cells themselves but on the body’s ability to combat them, they have the potential to treat multiple types of cancer.
Rgenix currently has several drug programs in clinical development, and Dr. Tavazoie joins the podcast to discuss each of them, as well as a range of other important and interesting topics in this new and exciting realm of cancer technology.
Tune in and visit <a href="https://rgenix.com/">https://rgenix.com/</a> for more.
Imagine an experience so immersive it truly feels like you’ve been transported to another world or transformed to fit the mold of a flying bird, your seat moving in tandem with the visual experience, your feet hanging in mid-air. Imagine being able to conveniently access such an experience with the whole family, leaving with a newfound sense of insight, motivation, inspiration, and appreciation for life.
This is exactly the type of experience MacGillivray Freeman, the family filmmaking company based out of Laguna Beach, CA, aims to provide for as many people as possible. “We are really good storytellers and that’s what we pride ourselves on, so being able to have something that is not only really cool and immersive but also emotional and inspirational, we strive for,” says Shaun MacGillivray, president of MacGillivray Freeman. He goes on to explain the impressive and important impacts of their films. For example, by partnering with the World Wildlife Fund (WWF) and Coca-Cola in a text-to-donate campaign inspired by their film To The Arctic, four million dollars were donated for a protected place for polar bears.
Shaun MacGillivray joins the podcast to discuss how the company began, how it’s evolved, what they’ve accomplished, and what’s in store for the future.
Press play to hear the full conversation, check out a handful of their films on Netflix and YouTube and learn more by visiting <a href="http://macgillivrayfreeman.com/our-story/">http://macgillivrayfreeman.com/our-story/</a>.
With the creation of an entirely inorganic robotic system about the size of a red blood cell—just seven to ten microns in diameter—the team in the lab of Michael Strano at the MIT Department of Engineering is reaching previously inaccessible locations in the human body and various other environments found within and useful to industry, such as chemical reactors, oil pipelines, and soil matrices.
In 2018, they published landmark papers detailing two prototypes of these tiny robotic systems, one which was used as a component of aerosolizable electronics in which they were nebulized and sent through a pipe, light enough to travel along with the air flow. The robots were able to detect different chemicals and respond to light within the pipes, and then be gathered for the collection of data. The second prototype was launched into a body of water where it was capable of detecting various chemicals and responding to magnetic fields, and therefore able to detect nutrients in soil matrices that were good or bad for plant growth.
Albert Liu is a presidential fellow and member of Michael Strano’s lab at MIT, and he has an extensive laboratory background. He brings a wealth of knowledge to the conversation, explaining the ins and outs of this new technology, the challenges that come along with creating and powering such small systems, and the tradeoffs between artificial and biological systems.
Press play for all the details, and learn more by visiting <a href="https://srg.mit.edu/">https://srg.mit.edu/</a>.
Mass producing colloidal electronics (with a video):
Nature Nano reference:
Nature Materials reference:
Jarett Boskovich, cofounder and chief marketing officer at WowYow Inc. (wowyow.com), delivers a comprehensive overview of his AI-based company’s exciting technology.
Boskovich has more than a decade of solid entrepreneurial experience and has worked with many successful Fortune 500 companies. With a distinguished background operating in sales and marketing, Boskovich seeks to bring all of his skills to WowYow Inc., the advanced AI-based company he cofounded.
Boskovich’s company has developed sophisticated technology that can scan video content to unlatch fresh supply and demand sources that can solve an assortment of digital media problems. Boskovich talks about WowYow’s position in the digital media space as a forward-thinking visual AI company. As he states, WowYow’s AI can be used to identify, index, search, and monetize visual content, across multiple platforms and devices. It’s people, places, products and things… in useable metadata delivery. As he explains, users can literally search video and unlock the data within. Imagine seeing a pro baller’s sneakers in a game, and wanting to know what they are, and if you could buy them for yourself… WowYow can help.
The tech entrepreneur talks about the depth of data that companies can use to create business opportunities. He states that while many things can be identified in video content, not every piece needs to be, or should be, so the technology is expanding as are the safeguards. Boskovich discusses the kinds of content in which the AI can be utilized to assist consumers.
The innovative company seeks to turn the industry on its ear, to literally change how we interact with and monetize deep visual content to provide an intense, original experience for businesses and companies as well as consumers interacting from various devices and platforms. Boskovich has high expectations for his company, and the company is working continuously to expand further into augmented reality, television, gaming consoles, and virtual reality.
Moving forward, Boskovich states they will be rolling out many new platform innovations that will create all new ad experiences for consumers. As the technology expands, Boskovich will be working with his team to bridge all tech gaps to make the consumer experience more exciting and productive.
One in two people around the world who have dementia will never receive a diagnosis for it, and those that do will likely receive it too late for existing treatments to be helpful. This is a problem that’s not only depriving patients of quality time, but also costing significant amounts of money due to earlier needs for residential care.
As it currently stands, testing for dementia usually begins only after a patient or their friends and family members notice cognitive impairment, usually in the form of forgetfulness. Once memory problems set in, however, it’s usually too late to slow the progression of the disease. In addition, the current tests designed to identify and help a clinician diagnose dementia rely on rudimentary, pen-and-paper tests that depend heavily on self-reporting. Cognetivity is a company that's offering a new type of test that could change all of this.
COO of Cognetivity, Tom Sawyer, explains that much like blood pressure or cholesterol check, their test can be completed as part of a routine physical exam. The premise of the test is quite simple and involves showing patients different images for a short duration and then prompting them to say something about the content of the images they’re shown. Capable of detecting very small changes in cognitive function and mild incompetencies that no test before it has been able to, it can identify pre-symptomatic stages of dementia 10 to 15 years before most people would receive a diagnosis today. This significantly earlier detection allows for the implementation of behavioral and lifestyle changes, mental exercises, and some medications in order to delay the progression of the disease and the need for residential care.
Tune in to hear the full conversation and visit <a href="http://cognetivity.com">cognetivity.com</a> to learn more.
Miriam Kalamian, EdM, MS, CNS, discusses her work as an educator and nutrition expert, and talks extensively about the connection between diet and disease.
Kalamian has devoted much of her life to the study of nutrition. She is board certified in nutrition (CNS), bestowed upon her by the Board for Certification of Nutrition Specialists. As a noted nutrition consultant and educator, she spends a great deal of her time focused on the importance of diet in an overall healthy lifestyle. And as a successful author and nutrition expert she is interested in the implementation of ketogenic therapies, and has written extensively on the topic. Kalamian holds a master of education (EdM) from Smith College and a master of human nutrition (MS) from Eastern Michigan University.
Kalamian discusses her background and what led to her current career focus. As she recounts, her world was rocked back in 2004 when her young son was diagnosed with a brain tumor. Standard therapies did not stop the aggressive progression of his disease, and thus it was clear to Kalamian that she simply had to go in a different direction to fight for her son. After much reading and research, Kalamian discovered Dr. Thomas Seyfried’s extensive research that was based on the ketogenic diet as a means to fight cancer. She discusses in detail, the journey she went through with her son, and talks about the ways in which the body turns up its power to fight, when a stricter diet commands the body to work efficiently.
The nutrition expert delves into the inner-workings of the body and its abilities to handle and process foods. She talks about the effects of too much protein in a diet, and explains what happens internally. She explains how cancer cells work and how exercise and diet combine to provide benefits. Kalamian explains fatty acids and ketosis, and the removal of glucose from the bloodstream. As she states, low-impact exercise, such as a nice walk, helps to remove glucose from the bloodstream in a safe and effective way. She explains that nutrition, when controlled, can benefit the body’s health while simultaneously working against cancer.
The effects of a ketogenic diet can have a significant impact on some cancer patients in combination with their doctor’s other treatments and therapies. While keto may not be the sole solution, it certainly can enhance traditional medicine treatments.